It is worth mentioning that those patients with higher BMIs or with improper glucose control shown by a high HbA1c would benefit from a more diligent screening of UTI via urine culture after initiating treatment with SGLT2 inhibitors. The gene discussed is SLC5A2; the disease is bacterial urinary tract infection.